470 related articles for article (PubMed ID: 29169146)
1. How bacteria control the CRISPR-Cas arsenal.
Leon LM; Mendoza SD; Bondy-Denomy J
Curr Opin Microbiol; 2018 Apr; 42():87-95. PubMed ID: 29169146
[TBL] [Abstract][Full Text] [Related]
2. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
Bradde S; Mora T; Walczak AM
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
[TBL] [Abstract][Full Text] [Related]
3. Modeling bacterial immune systems: strategies for expression of toxic - but useful - molecules.
Djordjevic M
Biosystems; 2013 May; 112(2):139-44. PubMed ID: 23499818
[TBL] [Abstract][Full Text] [Related]
4. Resistance is not futile: bacterial 'innate' and CRISPR-Cas 'adaptive' immune systems.
Fineran PC
Microbiology (Reading); 2019 Aug; 165(8):834-841. PubMed ID: 30958259
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
[TBL] [Abstract][Full Text] [Related]
6. The Biology of CRISPR-Cas: Backward and Forward.
Hille F; Richter H; Wong SP; Bratovič M; Ressel S; Charpentier E
Cell; 2018 Mar; 172(6):1239-1259. PubMed ID: 29522745
[TBL] [Abstract][Full Text] [Related]
7. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
[TBL] [Abstract][Full Text] [Related]
8. Conquering CRISPR: how phages overcome bacterial adaptive immunity.
Malone LM; Birkholz N; Fineran PC
Curr Opin Biotechnol; 2021 Apr; 68():30-36. PubMed ID: 33113496
[TBL] [Abstract][Full Text] [Related]
9. Adaptation in CRISPR-Cas Systems.
Sternberg SH; Richter H; Charpentier E; Qimron U
Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
[TBL] [Abstract][Full Text] [Related]
10. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
[TBL] [Abstract][Full Text] [Related]
11. The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages.
Smith LM; Jackson SA; Malone LM; Ussher JE; Gardner PP; Fineran PC
Nat Microbiol; 2021 Feb; 6(2):162-172. PubMed ID: 33398095
[TBL] [Abstract][Full Text] [Related]
12. The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.
Westra ER; van Houte S; Gandon S; Whitaker R
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20190101. PubMed ID: 30905294
[No Abstract] [Full Text] [Related]
13. Bacterial alginate regulators and phage homologs repress CRISPR-Cas immunity.
Borges AL; Castro B; Govindarajan S; Solvik T; Escalante V; Bondy-Denomy J
Nat Microbiol; 2020 May; 5(5):679-687. PubMed ID: 32203410
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas systems: beyond adaptive immunity.
Westra ER; Buckling A; Fineran PC
Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
[TBL] [Abstract][Full Text] [Related]
15. Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.
Gholizadeh P; Aghazadeh M; Asgharzadeh M; Kafil HS
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2043-2051. PubMed ID: 28601970
[TBL] [Abstract][Full Text] [Related]
16. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
Chaudhary K; Chattopadhyay A; Pratap D
J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
[TBL] [Abstract][Full Text] [Related]
17. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
[TBL] [Abstract][Full Text] [Related]
18. How adaptive immunity constrains the composition and fate of large bacterial populations.
Bonsma-Fisher M; Soutière D; Goyal S
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7462-E7468. PubMed ID: 30038015
[TBL] [Abstract][Full Text] [Related]
19. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
Hwang S; Maxwell KL
CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
[TBL] [Abstract][Full Text] [Related]
20. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.
Goldberg GW; Jiang W; Bikard D; Marraffini LA
Nature; 2014 Oct; 514(7524):633-7. PubMed ID: 25174707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
